Home › Insys CEO Babich resigns, drugmaker tops 3Q expectations
 

Keywords :   


Insys CEO Babich resigns, drugmaker tops 3Q expectations

2015-11-05 19:25:14| Biotech - Topix.net

Michael L. Babich has resigned as president and CEO of Insys Therapeutics, a specialty drugmaker under investigation over sales of its powerful painkiller Subsys. Shares of the Chandler, Arizona, company jumped almost 10 percent Thursday morning as the company also announced third-quarter earnings that trumped analyst expectations and said it was buying back some stock.

Tags: ceo expectations tops resigns

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »